BR112021000105A2 - Peptídeos, composição farmacêutica, método de preparação desta e método para tratamento de um distúrbio em um paciente com necessidade de modulação do tônus do músculo liso - Google Patents
Peptídeos, composição farmacêutica, método de preparação desta e método para tratamento de um distúrbio em um paciente com necessidade de modulação do tônus do músculo liso Download PDFInfo
- Publication number
- BR112021000105A2 BR112021000105A2 BR112021000105-0A BR112021000105A BR112021000105A2 BR 112021000105 A2 BR112021000105 A2 BR 112021000105A2 BR 112021000105 A BR112021000105 A BR 112021000105A BR 112021000105 A2 BR112021000105 A2 BR 112021000105A2
- Authority
- BR
- Brazil
- Prior art keywords
- seq
- peptide
- peptides
- ala
- fact
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694162P | 2018-07-05 | 2018-07-05 | |
| US62/694,162 | 2018-07-05 | ||
| US16/502,215 US10905738B2 (en) | 2018-07-05 | 2019-07-03 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
| US16/502,215 | 2019-07-03 | ||
| PCT/BR2019/050249 WO2020006617A1 (en) | 2018-07-05 | 2019-07-04 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021000105A2 true BR112021000105A2 (pt) | 2021-03-30 |
Family
ID=69059636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021000105-0A BR112021000105A2 (pt) | 2018-07-05 | 2019-07-04 | Peptídeos, composição farmacêutica, método de preparação desta e método para tratamento de um distúrbio em um paciente com necessidade de modulação do tônus do músculo liso |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10905738B2 (https=) |
| EP (1) | EP3818070B1 (https=) |
| JP (1) | JP7317956B2 (https=) |
| KR (1) | KR20210029161A (https=) |
| CN (1) | CN112654634B (https=) |
| BR (1) | BR112021000105A2 (https=) |
| CA (1) | CA3104183A1 (https=) |
| WO (1) | WO2020006617A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026507422A (ja) * | 2023-02-17 | 2026-03-04 | バイオゼウス バイオファーマシューティカル エス．エー． | 性機能障害の治療のための局所用ペプチド製剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| AT387234B (de) | 1987-03-05 | 1988-12-27 | Vogelbusch Gmbh | Vorrichtung zur zuechtung von dauerformen insbesondere filamentoeser mikroorganismen |
| US5470949A (en) | 1992-12-15 | 1995-11-28 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method for making amino acid glycosides and glycopeptides |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| US20030082671A1 (en) | 2001-07-24 | 2003-05-01 | Thomas Hoeg-Jensen | Method for making acylated polypeptides |
| US7585523B2 (en) | 2002-08-27 | 2009-09-08 | Targeted Medical Pharma | Composition and method to augment and sustain neurotransmitter production |
| CA2560956A1 (en) | 2004-03-29 | 2005-10-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Amphipathic glycopeptides |
| CN101563102B (zh) | 2006-09-22 | 2014-12-17 | 德克萨斯系统大学董事会 | 治疗内皮功能障碍的方法 |
| KR20090115852A (ko) | 2007-01-19 | 2009-11-09 | 카이 파마슈티컬즈 | 안정성 및 전달 효율을 증가시키기 위한 펩타이드 조성물의 변형 |
| BRPI0800596A2 (pt) | 2008-01-31 | 2009-09-22 | Univ Minas Gerais | método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer |
| CN101585872A (zh) | 2008-05-23 | 2009-11-25 | 成都蓉药集团四川长威制药有限公司 | 重组蛛毒蛋白、其制备方法和表达载体以及用于治疗ed的药物 |
| KR20130139254A (ko) | 2010-11-09 | 2013-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 피부 침투 및 세포 진입（ｓｐａｃｅ） 펩타이드 및 그의 사용방법 |
| PT2899198T (pt) * | 2012-08-20 | 2018-06-29 | Univ Federal De Minas Gerais Ufmg | Péptido sintético pntx(19), composições farmacêuticas e utilização |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| WO2015162195A1 (en) | 2014-04-23 | 2015-10-29 | Novo Nordisk A/S | Fatty acid acylated amino acids for oral peptide delivery |
| WO2017068388A2 (pt) | 2015-09-18 | 2017-04-27 | Universidade Federal De Minas Gerais - Ufmg | Uso do peptideo sintetico pntx-19 para tratamento de dor |
| KR101613302B1 (ko) | 2015-12-30 | 2016-04-18 | (주)넥스젠바이오텍 | Sv82 폴리펩타이드 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
| KR101636851B1 (ko) | 2016-06-03 | 2016-07-06 | (주)넥스젠바이오텍 | 피부 세포 증식 효과가 증가한 열 안정성 인간 상피세포성장인자-거미독 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선 및 탄력 유지용 화장료 조성물 |
-
2019
- 2019-07-03 US US16/502,215 patent/US10905738B2/en active Active
- 2019-07-04 BR BR112021000105-0A patent/BR112021000105A2/pt unknown
- 2019-07-04 CN CN201980057994.1A patent/CN112654634B/zh active Active
- 2019-07-04 KR KR1020207037684A patent/KR20210029161A/ko active Pending
- 2019-07-04 EP EP19830422.2A patent/EP3818070B1/en active Active
- 2019-07-04 CA CA3104183A patent/CA3104183A1/en active Pending
- 2019-07-04 WO PCT/BR2019/050249 patent/WO2020006617A1/en not_active Ceased
- 2019-07-04 JP JP2021522113A patent/JP7317956B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020006617A1 (en) | 2020-01-09 |
| US20200108118A1 (en) | 2020-04-09 |
| US10905738B2 (en) | 2021-02-02 |
| CA3104183A1 (en) | 2020-01-09 |
| CN112654634A (zh) | 2021-04-13 |
| JP2021530562A (ja) | 2021-11-11 |
| CN112654634B (zh) | 2022-05-27 |
| JP7317956B2 (ja) | 2023-07-31 |
| KR20210029161A (ko) | 2021-03-15 |
| EP3818070A4 (en) | 2022-03-16 |
| EP3818070B1 (en) | 2026-03-11 |
| EP3818070A1 (en) | 2021-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12285460B2 (en) | Pharmaceutical compositions | |
| KR101999756B1 (ko) | Ｃｄ36 발현을 감소시키는 방법 | |
| ES2632787T3 (es) | Análogos agonistas del receptor opioide mu de las endomorfinas | |
| ES2906173T3 (es) | Composiciones peptídicas y procedimientos de uso | |
| ES2750258T3 (es) | Métodos y composiciones para la prevención o tratamiento del síndrome de Barth | |
| TW201630621A (zh) | Ｋｖ１．３通道阻斷肽之局部施用以治療皮膚發炎 | |
| JP4147329B2 (ja) | 液体形態の改良された安定性を有するコルチコトロピン放出因子の医薬製剤 | |
| US20100004165A1 (en) | Novel Protein Transduction Domains and Uses Therefor | |
| EP3818070B1 (en) | Synthetic peptides, prodrugs, pharmaceutical compositions and uses | |
| AU2421492A (en) | Neurotensin method for inhibiting vascular leakage | |
| CA3238619A1 (en) | Pharmaceutical compositions for the treatment of visceral pain | |
| HK40043121B (en) | Synthetic peptides, prodrugs, pharmaceutical compositions and uses | |
| HK40043121A (en) | Synthetic peptides, prodrugs, pharmaceutical compositions and uses | |
| KR20020058003A (ko) | 발기 부전 치료용 펩티드 | |
| CN112334150B (zh) | 肽蛋白激酶c抑制剂及其用途 | |
| ES2965807T3 (es) | Combinación de temozolomida y un conjugado de PAR-1 para tratar el glioblastoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: BIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACEUTICOS S.A. (BR/RJ) Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 870250104124, DE 13/11/2025, E NECESSARIO APRESENTAR DOCUMENTO QUE EVIDENCIE A ALTERACAO DE NOME SOLICITADA. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B25D | Requested change of name of applicant approved |
Owner name: BIOZEUS BIOPHARMACEUTICAL S.A. (BR/RJ) |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |